Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Fabregat

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Carcinogenesis|December 20, 2005
Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthaseGema Santamaría, Marta Martínez-Diez, Isabel Fabregat, et al.
Journal of Cellular Physiology|October 15, 2010
The transforming growth factor-beta (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cellsLaia Caja, Esther Bertran, Jean Campbell, et al.
Biochemical Pharmacology|March 29, 2008
Inhibition of the EGF receptor blocks autocrine growth and increases the cytotoxic effects of doxorubicin in rat hepatoma cells: role of reactive oxygen species production and glutathione depletionConrad Ortiz, Laia Caja, Patricia Sancho, et al.
Pharmaceutics|May 7, 2020
Encapsulating TGF-β1 Inhibitory Peptides P17 and P144 as a Promising Strategy to Facilitate Their Dissolution and to Improve Their FunctionalizationNemany A N Hanafy, Isabel Fabregat, Stefano Leporatti, et al.
Cellular Signalling|October 4, 2011
Lack of amino acids in mouse hepatocytes in culture induces the selection of preneoplastic cellsAndrea N Chisari, Patricia Sancho, Laia Caja, et al.
Cancers|April 23, 2022
Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular CarcinomaFrancesco Dituri, Gianluigi Gigante, Rosanna Scialpi, et al.
World Journal of Gastroenterology|April 26, 2014
Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinomaBhavna Rani, Yuan Cao, Andrea Malfettone, et al.
Oncogene|April 28, 2005
Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytesMiguel M Murillo, Gaelle del Castillo, Aránzazu Sánchez, et al.
Journal of Neurochemistry|June 9, 2007
Apoptotic action of E2F1 requires glycogen synthase kinase 3-beta activity in PC12 cellsLilia Espada, Basavaraj Udapudi, Petar Podlesniy, et al.
Hepatology (Baltimore, Md.)|November 27, 2004
IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytesAngela M Valverde, Isabel Fabregat, Deborah J Burks, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Carcinogenesis|December 20, 2005
Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthaseGema Santamaría, Marta Martínez-Diez, Isabel Fabregat, et al.
Journal of Cellular Physiology|October 15, 2010
The transforming growth factor-beta (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cellsLaia Caja, Esther Bertran, Jean Campbell, et al.
Biochemical Pharmacology|March 29, 2008
Inhibition of the EGF receptor blocks autocrine growth and increases the cytotoxic effects of doxorubicin in rat hepatoma cells: role of reactive oxygen species production and glutathione depletionConrad Ortiz, Laia Caja, Patricia Sancho, et al.
Pharmaceutics|May 7, 2020
Encapsulating TGF-β1 Inhibitory Peptides P17 and P144 as a Promising Strategy to Facilitate Their Dissolution and to Improve Their FunctionalizationNemany A N Hanafy, Isabel Fabregat, Stefano Leporatti, et al.
Cellular Signalling|October 4, 2011
Lack of amino acids in mouse hepatocytes in culture induces the selection of preneoplastic cellsAndrea N Chisari, Patricia Sancho, Laia Caja, et al.
Cancers|April 23, 2022
Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular CarcinomaFrancesco Dituri, Gianluigi Gigante, Rosanna Scialpi, et al.
World Journal of Gastroenterology|April 26, 2014
Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinomaBhavna Rani, Yuan Cao, Andrea Malfettone, et al.
Oncogene|April 28, 2005
Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytesMiguel M Murillo, Gaelle del Castillo, Aránzazu Sánchez, et al.
Journal of Neurochemistry|June 9, 2007
Apoptotic action of E2F1 requires glycogen synthase kinase 3-beta activity in PC12 cellsLilia Espada, Basavaraj Udapudi, Petar Podlesniy, et al.
Hepatology (Baltimore, Md.)|November 27, 2004
IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytesAngela M Valverde, Isabel Fabregat, Deborah J Burks, et al.
Pageof 13